The first regulatory network in this regulation effect analysis shows that the dataset may be due to the regulation of PLK2, PLK4, TAZ, and VGLL3 through ADM, BASP1, CD44, CDH2, CITED2, COL12A1, CYP1B1, CYR61, EDN1, FN1, GADD45B, IFIT2, IL1B, MYOF, NAV3, PLAT, SERPINE1, SOX9, and THBS1 and other genes have an activating effect on lymphoma, morbidity or mortality, motor dysfunction, or movement disorder, inhibiting cell viability of tumor cell lines and microtubule dynamics (Figure 2(e)). The gene discussed is ADM; the disease is lymphoma.